Tech Company Financing Transactions
Intarcia Therapeutics Funding Round
On 3/19/2007, Intarcia Therapeutics received $50 million in Series B financing from New Leaf Venture Partners, Alta Partners and GGV Capital.
Transaction Overview
New Leaf Venture Partners (Lead Investor) (James Niedel)
New Enterprise Associates (Michael Raab)
Venrock (Bryan Roberts)
Company Information
Boston, MA 02210
USA
Management Team
Browse more venture capital transactions:
Prev: 3/19/2007: Theraclone Sciences venture capital transaction
Next: 3/19/2007: NeuroPure venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs